Jim Rechtin’s name has an odd space between two numbers that is worth stopping for before continuing. Based solely on his disclosed shares of Humana, one database estimates his net worth at approximately $1.46 million. Another, looking more broadly at his professional assets, comes in closer to $8 million. Exactly, neither is incorrect. They both likely underestimate what a man with a $19 million salary package is enjoying because they are simply measuring different things.
In July 2024, Rechtin succeeded Bruce Broussard, who had led Humana for over ten years, as CEO. Rechtin served as president and COO for the first half of 2024, getting to know the building before receiving the keys, so the handoff was well-planned. By corporate standards, this succession is exceptionally patient. The majority of CEOs enter cold. That was not what Humana wanted.
| Bio Data | Details |
|---|---|
| Full Name | James A. Rechtin |
| Born | 1970 or 1971, Covington, Kentucky |
| Age | 54–55 |
| Education | DePauw University (BA), Harvard Business School (MBA) |
| Current Role | President & CEO, Humana Inc. |
| CEO Since | July 2024 (President & COO from Jan 2024) |
| 2025 Total Compensation | $18.76 million |
| 2024 Total Compensation | $15.58 million |
| Estimated Net Worth (Benzinga) | $1.46 million (based on reported HUM shares) |
| Estimated Net Worth (GuruFocus) | At least $8 million (as of May 2026) |
| Direct Ownership in Humana | Approx. 0.012% of shares |
| Spouse | Stacy Rechtin |
| Children | 3 |
| Residence | Colorado |
| Previous Roles | CEO Envision Healthcare; President OptumCare; Partner, Bain & Company |
According to a DEF14A filing he made earlier this year, his 2025 compensation was $18,757,075, an increase of about 17% over the previous year. At this altitude, the structure is typical: bonuses and stock make up the remaining 7% of the salary. For better or worse, it’s the kind of combination that links a CEO’s wealth to the share price, and Humana’s share price hasn’t been kind recently.
That is important because the company is experiencing a problem. On November 5, 2025, Humana reduced its full-year guidance and reported net income of $1.62 per share, a significant decrease from $3.98 the previous year. Humana, which is more vulnerable than most, is feeling the pressure on Medicare Advantage margins. According to his own account, Rechtin has devoted a significant portion of his first eighteen months to listening, visiting offices, meeting with claims teams, and attempting to ascertain what is truly broken prior to issuing directives. It remains to be seen if investors will be more patient with him as a result.
His background doesn’t exactly match the executive pay slip, and it’s difficult to ignore this. He was raised in Indianapolis and Covington, Kentucky. He began his career at the nonprofit organization Horizon House, which helps those who are homeless. He served in the Peace Corps for two years. It was only then that he arrived at Bain, where he spent fourteen years before becoming a partner. It’s not the typical path from a nonprofit clinic to a Fortune 50 insurer’s corner office, and those who know him usually bring up the early chapters first. Make what you want out of that.
According to documents tracked on Simply Wall St., his ownership stake in Humana is small in percentage terms—roughly 0.012 percent of the company—but worth several million euros at current prices. When the stock was at $229.25 in May 2025, he purchased 6,530 shares for about $1.5 million. Some observers saw this open-market purchase as a signal. Seldom do insiders purchase unless they are convinced. However, insiders also seldom purchase at the top.
Around Humana, there is a feeling that Rechtin is still being evaluated. Whether it is $1.46 million now or something much higher five years from now, the amount that is written next to his name will almost entirely depend on his ability to stabilize a faltering company. The pay is predetermined. The luck isn’t.
